﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Generated by www.ashp.org on Fri, 20 Nov 2009 21:17:41--><rss version="2.0"><channel><title>ASHP Health-System Pharmacy News</title><link>http://www.ashp.org/Import/NEWS/HealthSystemPharmacyNews.aspx</link><description>ASHP Health-System Pharmacy News</description><language>en-us</language><copyright>Copyright2009 ASHP</copyright><docs>http://blogs.law.harvard.edu/tech/rss/</docs><lastBuildDate>Fri, 20 Nov 2009 21:17:41</lastBuildDate><image><url>http://www.ashp.org/images/ashprss.gif</url><title>ASHP</title><link>http://www.ashp.org/</link><width>57</width><height>34</height></image><item><title><![CDATA[Vicks Sinex Spray Recalled]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3222</link><description><![CDATA[Procter &amp; Gamble yesterday announced the recall of Vicks Sinex 15 mL nasal spray because certain lots of the nonprescription product may be contaminated with Burkholderia cepacia.]]></description><category>ASHP Action Line</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3222</guid><pubDate>Fri, 20 Nov 2009</pubDate></item><item><title><![CDATA[Omeprazole Decreases Effectiveness of Clopidogrel, FDA Says]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3221</link><description><![CDATA[Patients who are taking clopidogrel should avoid the concomitant use of omeprazole, a proton-pump inhibitor (PPI), because the latter drug diminishes the antiplatelet effects of clopidogrel, FDA announced today.]]></description><category>ASHP Action Line</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3221</guid><pubDate>Tue, 17 Nov 2009</pubDate></item><item><title><![CDATA[Contaminants Found in Some Genzyme Product Lots]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3220</link><description><![CDATA[Particulate contaminants including stainless steel fragments, rubber, and fibrous material have been discovered during quality testing of five injectable products manufactured by Genzyme, FDA announced today.]]></description><category>ASHPNews</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3220</guid><pubDate>Fri, 13 Nov 2009</pubDate></item><item><title><![CDATA[Some Unused Narcotics Should Go Down the Drain, FDA Says]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3219</link><description><![CDATA[FDA in October highlighted a small but serious public health risk by asking consumers to remove certain leftover narcotics from the household by flushing them away or pouring them down a sink.]]></description><category>AJHP</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3219</guid><pubDate>Fri, 13 Nov 2009</pubDate></item><item><title><![CDATA[Joint Commission Updates National Patient Safety Goals for 2010]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3218</link><description><![CDATA[No new items have been added to the Joint Commission's list of National Patient Safety Goals (NPSGs) for 2010, but the list has been refined and shortened, and more changes are expected in the future.]]></description><category>AJHP</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3218</guid><pubDate>Fri, 13 Nov 2009</pubDate></item><item><title><![CDATA[International Hospital Pharmacy Section Reorganizes To Promote Basel Statements]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3217</link><description><![CDATA[The Hospital Pharmacy Section (HPS) of the International Pharmaceutical Federation (FIP) is adjusting its organizational structure to help in implementing the consensus statements from the 2008 Global Conference on the Future of Hospital Pharmacy, held in Basel, Switzerland.]]></description><category>AJHP</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3217</guid><pubDate>Thu, 12 Nov 2009</pubDate></item><item><title><![CDATA[Health System Views Pharmacist as Vital to Coordinated Care]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3216</link><description><![CDATA[For more than a year, a rural health system in central Minnesota has been offering select patients a medical home, complete with a pharmacist.]]></description><category>AJHP</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3216</guid><pubDate>Thu, 12 Nov 2009</pubDate></item><item><title><![CDATA[Hospira Recalls Propofol, Liposyn]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3215</link><description><![CDATA[Hospira alerted health care professionals yesterday that the company has recalled dozens of lots of the sedative propofol and the i.v. nutritional supplement Liposyn that may be contaminated with metal particles.]]></description><category>ASHPNews</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3215</guid><pubDate>Tue, 10 Nov 2009</pubDate></item><item><title><![CDATA[McNeil Recalls Five Lots of Tylenol Arthritis Pain]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3214</link><description><![CDATA[McNeil Consumer Healthcare on November 6 announced a recall of Tylenol Arthritis Pain caplets in lots 08BMC013, 08BMC020, 09BMC034, 09CMC036, and 09CMC040 after detecting an "uncharacteristic" smell or taste.]]></description><category>ASHPNews</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3214</guid><pubDate>Tue, 10 Nov 2009</pubDate></item><item><title><![CDATA[Covidien Contraindicates Optimark in Severe Renal Insufficiency]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3212</link><description><![CDATA[A month before two FDA advisory committees meet to discuss the safety of gadolinium-based contrast agents, the manufacturer of one of the agents has declared its product inadvisable for use in patients with severe renal impairment.]]></description><category>ASHPNews</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3212</guid><pubDate>Mon, 09 Nov 2009</pubDate></item></channel></rss>